Introduction to epigenomics and epigenome-wide analysis.

[1]  M. Ratner Human Genome Sciences trial data wow lupus community , 2009, Nature Biotechnology.

[2]  A. Feinberg,et al.  Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.

[3]  David J Hand,et al.  Breast Cancer Diagnosis from Proteomic Mass Spectrometry Data: A Comparative Evaluation , 2008, Statistical applications in genetics and molecular biology.

[4]  Shuji Ogino,et al.  A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. , 2008, Journal of the National Cancer Institute.

[5]  Thomas Mikeska,et al.  Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene , 2008, Epigenetics & Chromatin.

[6]  A. Urban,et al.  MEDME: an experimental and analytical methodology for the estimation of DNA methylation levels based on microarray derived MeDIP-enrichment. , 2008, Genome research.

[7]  O. Rando,et al.  Reduced-representation methylation mapping , 2008, Genome Biology.

[8]  Z. Herceg,et al.  Epigenetic interplay between histone modifications and DNA methylation in gene silencing. , 2008, Mutation research.

[9]  R. Durbin,et al.  A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis , 2008, Nature Biotechnology.

[10]  Jon Wakefield,et al.  Reporting and interpretation in genome-wide association studies. , 2008, International journal of epidemiology.

[11]  Rafael A Irizarry,et al.  Comprehensive high-throughput arrays for relative methylation (CHARM). , 2008, Genome research.

[12]  Quan Chen,et al.  An analytical pipeline for genomic representations used for cytosine methylation studies , 2008, Bioinform..

[13]  Stephan Beck,et al.  The methylome: approaches for global DNA methylation profiling. , 2008, Trends in genetics : TIG.

[14]  Peter Gibbs,et al.  Cytosine methylation profiling of cancer cell lines , 2008, Proceedings of the National Academy of Sciences.

[15]  Steven Piantadosi,et al.  DNA methylation markers and early recurrence in stage I lung cancer. , 2008, The New England journal of medicine.

[16]  Jonathan Pevsner,et al.  DNA methylation signatures within the human brain. , 2007, American journal of human genetics.

[17]  Steven Henikoff,et al.  Genome-wide analysis of DNA methylation patterns , 2007, Development.

[18]  R. Jaenisch,et al.  DNA Methylation in the Human Cerebral Cortex Is Dynamically Regulated throughout the Life Span and Involves Differentiated Neurons , 2007, PloS one.

[19]  Dong Xu,et al.  Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. , 2007, Cancer research.

[20]  J. Rogers,et al.  DNA methylation profiling of human chromosomes 6, 20 and 22 , 2006, Nature Genetics.

[21]  Kenny Q. Ye,et al.  Comparative isoschizomer profiling of cytosine methylation: the HELP assay. , 2006, Genome research.

[22]  Wei Jiang,et al.  High-throughput DNA methylation profiling using universal bead arrays. , 2006, Genome research.

[23]  B. Weinhold Epigenetics: The Science of Change , 2006, Virchows Archiv.

[24]  A. Bird,et al.  Genomic DNA methylation: the mark and its mediators. , 2006, Trends in biochemical sciences.

[25]  T. Gingeras,et al.  Microarray-based DNA methylation profiling: technology and applications , 2022 .

[26]  A. Feinberg,et al.  The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.

[27]  Peter L Molloy,et al.  DNA methylation: Bisulphite modification and analysis , 2006, Nature Protocols.

[28]  R. Martienssen,et al.  RNA interference and heterochromatin in the fission yeast Schizosaccharomyces pombe. , 2005, Trends in genetics : TIG.

[29]  Annette M. Molinaro,et al.  Prediction error estimation: a comparison of resampling methods , 2005, Bioinform..

[30]  W. Lam,et al.  Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells , 2005, Nature Genetics.

[31]  J. Issa CpG island methylator phenotype in cancer , 2004, Nature Reviews Cancer.

[32]  I. Gut,et al.  De novo quantitative bisulfite sequencing using the pyrosequencing technology. , 2004, Analytical biochemistry.

[33]  Edith Heard,et al.  Recent advances in X-chromosome inactivation. , 2004, Current opinion in cell biology.

[34]  John M. Greally,et al.  Epigenomics: beyond CpG islands , 2004, Nature Reviews Genetics.

[35]  Nathaniel Rothman,et al.  Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies , 2004 .

[36]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[37]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  B. Richardson Impact of aging on DNA methylation , 2003, Ageing Research Reviews.

[39]  Hoguen Kim,et al.  Concerted promoter hypermethylation of hMLH1, p16INK4A, and E‐cadherin in gastric carcinomas with microsatellite instability , 2003, The Journal of pathology.

[40]  Rachel Jones,et al.  Behavioural genetics: Worms gang up on bacteria , 2002, Nature Reviews Genetics.

[41]  B. Iacopetta,et al.  Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands , 2002, Gut.

[42]  C. Carpenter,et al.  DNA methylation analysis: a powerful new tool for lung cancer diagnosis , 2002, Oncogene.

[43]  B. Richardson,et al.  Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer. , 2002, The Journal of nutrition.

[44]  Terry L. Smith,et al.  DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  T. Efferth,et al.  Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation. , 2002, Methods.

[46]  P. Laird,et al.  Analysis of complex methylation data. , 2002, Methods.

[47]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[48]  S. Dudoit,et al.  Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data , 2002 .

[49]  A. Bird,et al.  MeCP2 and other methyl-CpG binding proteins. , 2002, Mental retardation and developmental disabilities research reviews.

[50]  Robert Brown,et al.  Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes. , 2001, The American journal of pathology.

[51]  Trevor Hastie,et al.  The Elements of Statistical Learning , 2001 .

[52]  G. Felsenfeld,et al.  Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene , 2000, Nature.

[53]  P. Laird,et al.  MethyLight: a high-throughput assay to measure DNA methylation. , 2000, Nucleic acids research.

[54]  R H Hruban,et al.  Hypermethylation of multiple genes in pancreatic adenocarcinoma. , 2000, Cancer research.

[55]  N. Ahuja,et al.  Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[56]  S. Baylin,et al.  Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. , 1999, Cancer research.

[57]  M. Toyota,et al.  CpG island methylator phenotypes in aging and cancer. , 1999, Seminars in cancer biology.

[58]  J. Herman,et al.  Hypermethylation of tumor suppressor genes in cancer. , 1999, Seminars in cancer biology.

[59]  J. Herman,et al.  CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[60]  S. Baylin,et al.  Concordant methylation of the ER and N33 genes in glioblastoma multiforme , 1998, Oncogene.

[61]  P. Laird Oncogenic mechanisms mediated by DNA methylation. , 1997, Molecular medicine today.

[62]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[63]  S. Clark,et al.  High sensitivity mapping of methylated cytosines. , 1994, Nucleic acids research.

[64]  R. Tibshirani,et al.  An Introduction to the Bootstrap , 1995 .

[65]  E. Raleigh,et al.  McrBC: a multisubunit GTP-dependent restriction endonuclease. , 1992, Journal of molecular biology.

[66]  L. E. McDonald,et al.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[67]  A. Atkinson Subset Selection in Regression , 1992 .

[68]  A. Feinberg,et al.  Reduced genomic 5-methylcytosine content in human colonic neoplasia. , 1988, Cancer research.

[69]  M. Frommer,et al.  CpG islands in vertebrate genomes. , 1987, Journal of molecular biology.

[70]  A. Bird CpG-rich islands and the function of DNA methylation , 1986, Nature.

[71]  M. Ehrlich,et al.  The 5-methylcytosine content of DNA from human tumors. , 1983, Nucleic acids research.

[72]  A. Bird DNA methylation and the frequency of CpG in animal DNA. , 1980, Nucleic acids research.

[73]  S. Holm A Simple Sequentially Rejective Multiple Test Procedure , 1979 .